September 2021 edition of ABG Sundal Collier's monthly Biotech update. An overview of the newsflow in August and near-term milestones. An overview of our universe of Swedish Biotech stocks.
Demant has enjoyed a strong run YTD, less ST upside GN Store Nord’s share has faced headwind lately… …which we find exaggerated. GN still a preferred BUY
OCEAN (and PORT) abstracts released ahead of IMW No details on sub-group OS data in abstract Maintain that confirmatory clinical trial data likely needed